Latest news with #ReckittBenckiser
Associated Press
2 days ago
- Business
- Associated Press
RBGLY DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Reckitt Benckiser Group PLC Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York--(Newsfile Corp. - July 27, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ('ADSs') of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 and July 28, 2024, both dates inclusive (the 'Class Period'), of the important August 4, 2025 lead plaintiff deadline. SO WHAT: If you purchased Reckitt ADSs you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Reckitt class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants failed to warn investors and consumers: (1) that preterm infants were at an increased risk of developing necrotizing enterocolitis ('NEC') by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, defendants' positive statements about Reckitt's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Reckitt action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit
Yahoo
3 days ago
- Business
- Yahoo
Reckitt Benckiser Group (LON:RKT) Will Pay A Dividend Of £0.844
The board of Reckitt Benckiser Group plc (LON:RKT) has announced that it will pay a dividend on the 18th of September, with investors receiving £0.844 per share. This makes the dividend yield 3.6%, which is above the industry average. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Reckitt Benckiser Group's Future Dividend Projections Appear Well Covered By Earnings If the payments aren't sustainable, a high yield for a few years won't matter that much. Based on the last payment, Reckitt Benckiser Group's profits didn't cover the dividend, but the company was generating enough cash instead. Given that the dividend is a cash outflow, we think that cash is more important than accounting measures of profit when assessing the dividend, so this is a mitigating factor. The next year is set to see EPS grow by 119.0%. If the dividend continues along recent trends, we estimate the payout ratio will be 53%, which would make us comfortable with the sustainability of the dividend, despite the levels currently being quite high. View our latest analysis for Reckitt Benckiser Group Reckitt Benckiser Group Has A Solid Track Record The company has a sustained record of paying dividends with very little fluctuation. The annual payment during the last 10 years was £1.39 in 2015, and the most recent fiscal year payment was £2.02. This works out to be a compound annual growth rate (CAGR) of approximately 3.8% a year over that time. Although we can't deny that the dividend has been remarkably stable in the past, the growth has been pretty muted. Reckitt Benckiser Group's Dividend Might Lack Growth Investors who have held shares in the company for the past few years will be happy with the dividend income they have received. Reckitt Benckiser Group has impressed us by growing EPS at 37% per year over the past five years. While EPS is growing rapidly, Reckitt Benckiser Group paid out a very high 113% of its income as dividends. If earnings continue to grow, this dividend may be sustainable, but we think a payout this high definitely bears watching. Our Thoughts On Reckitt Benckiser Group's Dividend In summary, while it's always good to see the dividend being raised, we don't think Reckitt Benckiser Group's payments are rock solid. The company has been bring in plenty of cash to cover the dividend, but we don't necessarily think that makes it a great dividend stock. Overall, we don't think this company has the makings of a good income stock. Companies possessing a stable dividend policy will likely enjoy greater investor interest than those suffering from a more inconsistent approach. However, there are other things to consider for investors when analysing stock performance. For instance, we've picked out 3 warning signs for Reckitt Benckiser Group that investors should take into consideration. If you are a dividend investor, you might also want to look at our curated list of high yield dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Globe and Mail
4 days ago
- Business
- Globe and Mail
Levi & Korsinsky Notifies Reckitt Benckiser Group plc (RBGLY) Investors - Lead Plaintiff Deadline on August 4, 2025
New York, New York--(Newsfile Corp. - July 25, 2025) - If you suffered a loss on your Reckitt Benckiser Group plc (OTCQX: RBGLY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Reckitt Benckiser Group plc that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) preterm infants were at an increased risk of developing NEC by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. WHAT'S NEXT? If you suffered a loss in Reckitt Benckiser Group plc stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes. To view the source version of this press release, please visit
Daily Mail
5 days ago
- Business
- Daily Mail
Footsie hits another record high on hopes of a trade deal between the US and the EU
The FTSE 100 scaled new highs yesterday as hopes of a trade deal between the US and the EU gave global stock markets a lift. With traders also cheering upbeat results from the likes of Reckitt Benckiser and BT – and eyeing potential interest rate cuts this summer – the blue-chip index rose 0.9 per cent, or 76.88 points, to 9138.37. That took gains for the year to close to 12 per cent. 'The FTSE 100 has sprung to life,' said David Morrison, senior market analyst at Trade Nation. 'Having broken above 9000 for the first time ever at the beginning of last week, upside momentum has been building.' The mood has been buoyed by cooling trade tensions around the world following Donald Trump's trade deal with Japan. It is now hoped that the European Union will reach a similar agreement with America – though the terms look set to be worse than those secured by Britain. In what has been hailed as a Brexit dividend, most British exports to the US face tariffs of 10 per cent, compared to the 15 per cent rate that has been secured by Japan and targeted by Brussels. Cooling trade tensions as well as upbeat corporate results have boosted share prices lately. Investors also believe the Bank of England will cut UK interest rates next month. The latest rally came despite a 9.5 per cent slump in the Tesla share price in New York yesterday after boss Elon Musk warned of 'a few rough quarters' ahead. 'European shares marched higher as the positive sentiment generated by the trade deal agreed between the US and Japan continued to permeate the markets,' said AJ Bell investment director Russ Mould. 'The continued momentum came despite a mixed start to the big tech earnings season across the Atlantic, with some well-received corporate results helping to support UK stocks as the FTSE 100 sailed through the 9100 barrier.' Neil Wilson, UK investor strategist at Saxo Markets, said: 'The winning streak continues with the index jumping to a fresh record. Hopeful noises on trade with the EU and the US heading towards a Japan-style 15 per cent tariff rate is enough to support the mood.'
Wall Street Journal
6 days ago
- Business
- Wall Street Journal
Reckitt Benckiser Raises Outlook After Adjusted Profit Beats Expectations
Consumer-goods company Reckitt Benckiser RKT -0.04%decrease; red down pointing triangle reported market-beating adjusted profit as cost savings paid off and raised its full-year outlook. The U.K. company on Thursday said first-half adjusted operating profit, which strips out exceptional and other one-off items, rose 1.8% on year to 1.71 billion pounds ($2.32 billion). A company-provided market consensus forecast 1.66 billion pounds. Reckitt said the rise reflects efficiency improvements and early delivery of costs savings.
